Dashboard
Manage Tickers

CVRXCVRx, Inc.

Nasdaq cvrx.com


$ 7.67 $ -0.18 (-2.29 %)    

Monday, 16-Sep-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.20 (-0.46 %)
DIA $ 417.33 $ 2.39 (0.58 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 7.68
$ 7.99
$ 7.64 x 100
-- x --
$ 7.53 - $ 7.99
$ 6.40 - $ 33.14
446,616
na
171.02M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-09-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 02-10-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cvrx-announces-new-publication-reinforcing-the-long-term-quality-of-life-benefits-of-barostim
CVRx Announces New Publication Reinforcing...
09/12/2024 12:12:20

New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart fai...

cantor-fitzgerald-initiates-coverage-on-cvrx-with-overweight-rating-announces-price-target-of-14
Cantor Fitzgerald Initiates Coverage On CV...
09/10/2024 12:23:34

Cantor Fitzgerald analyst Ross Osborn initiates coverage on CVRx (NASDAQ:CVRX) with a Overweight rating and announces Price ...

cvrx-stock-a-deep-dive-into-analyst-perspectives-5-ratings
CVRx Stock: A Deep Dive Into Analyst Persp...
08/26/2024 19:00:52

lake-street-reiterates-buy-on-cvrx-maintains-12-price-target
Lake Street Reiterates Buy on CVRx, Mainta...
08/26/2024 17:45:19

Lake Street analyst Frank Takkinen reiterates CVRx (NASDAQ:CVRX) with a Buy and maintains $12 price target.

cvrx-announces-cms-reassignment-of-barostim-implant-procedure-to-ms-drg-276-with-43000-national-average-payment-in-fy-2025-medicare-hospital-inpatient-prospective-payment-system
CVRx Announces CMS Reassignment Of Barosti...
08/02/2024 12:06:24

New Payment Effective October 1, 2024

what-analysts-are-saying-about-cvrx-stock
What Analysts Are Saying About CVRx Stock
07/30/2024 12:00:59

piper-sandler-maintains-overweight-on-cvrx-lowers-price-target-to-13
Piper Sandler Maintains Overweight on CVRx...
07/30/2024 11:28:37

Piper Sandler analyst Matt O'Brien maintains CVRx (NASDAQ:CVRX) with a Overweight and lowers the price target from $15 t...

canaccord-genuity-maintains-buy-on-cvrx-raises-price-target-to-15
Canaccord Genuity Maintains Buy on CVRx, R...
07/30/2024 11:01:57

Canaccord Genuity analyst William Plovanic maintains CVRx (NASDAQ:CVRX) with a Buy and raises the price target from $14 to $15.

cvrx-continues-to-expect-fy24-total-revenue-of-50m---53m-est-50803m
CVRx Continues To Expect FY24 Total Revenu...
07/29/2024 20:53:28

For the full year of 2024, the Company now expects: Total revenue between $50.0 million and $53.0 million; Gross margin bet...

cvrx-expects-to-report-q3-total-revenue-of-127m---137m-est-1351m
CVRx Expects To Report Q3 Total Revenue Of...
07/29/2024 20:47:23

cvrx-q2-2024-gaap-eps-065-misses-053-estimate-sales-11807m-beat-11787m-estimate
CVRx Q2 2024 GAAP EPS $(0.65) Misses $(0.5...
07/29/2024 20:18:43

CVRx (NASDAQ:CVRX) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22....

craig-hallum-maintains-buy-on-cvrx-lowers-price-target-to-15
Craig-Hallum Maintains Buy on CVRx, Lowers...
07/11/2024 16:37:01

Craig-Hallum analyst Alexander Nowak maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $23 to $15.

navigating-6-analyst-ratings-for-cvrx
Navigating 6 Analyst Ratings For CVRx
07/11/2024 16:00:15

lake-street-maintains-buy-on-cvrx-lowers-price-target-to-12
Lake Street Maintains Buy on CVRx, Lowers ...
07/11/2024 15:24:04

Lake Street analyst Frank Takkinen maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $18 to $12.

watching-shares-of-cvrx-shares-move-lower-as-traders-circulate-report-that-canaccord-says-cvrx-faces-significant-reimbursement-cut-in-cms-proposal-barostim-procedures-reimbursement-may-drop-from-45k-to-31222-next-year-final-ruling-expected-early-november
Watching Shares Of CVRx, Shares Move Lower...
07/10/2024 16:43:31

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/17/2024 20:31:09

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 16:31:03

cvrx-reiterated-fy24-outlook-for-revenue-at-500m-530m-vs-508m-est-gross-margin-of-830-850
CVRx Reiterated FY24 Outlook For Revenue A...
06/05/2024 10:52:20

lake-street-maintains-buy-on-cvrx-lowers-price-target-to-18
Lake Street Maintains Buy on CVRx, Lowers ...
05/01/2024 19:46:21

Lake Street analyst Frank Takkinen maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $35 to $18.

canaccord-genuity-maintains-buy-on-cvrx-lowers-price-target-to-14
Canaccord Genuity Maintains Buy on CVRx, L...
05/01/2024 18:52:31

Canaccord Genuity analyst William Plovanic maintains CVRx (NASDAQ:CVRX) with a Buy and lowers the price target from $32 to $14.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION